Clinical Trial Update: Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating botulinum toxin to improve cosmetic outcomes after primary cleft lip repair has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cleft Lip

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cleft Lip, Scarring | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-03